Cost-benefit analysis in U.S. regulatory decision-making
What does the future hold?
The Society for Benefit-Cost Analysis1 recently shared a blog titled: On Balance: Will U.S. Regulatory Benefit-Cost Analysis Survive? by: Lisa A. Robinson, Harvard T.H. Chan School of Public Health
I was particularly taken with the author’s description of CBA as a “voyage of discovery” - a view I strongly share:
Textbooks describe the goal of benefit-cost…
Keep reading with a 7-day free trial
Subscribe to Evaluation and Value for Investment to keep reading this post and get 7 days of free access to the full post archives.